News & Events

• January 31, 2017
  

  Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: A View of the Regulatory Science Qualification Landscape from the Coalition Against Major Diseases CSF Biomarker Team

• August 19, 2016
  

  Alzheimer’s disease patient groups derived from a multivariate analysis of cognitive test outcomes in the Coalition Against Major Diseases dataset

• April 22, 2016
  

  Sex-specific patterns and differences in dementia and Alzheimer’s disease using informatics approaches

   ...
• March 1, 2015
  

  Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease

  Perry D, Sperling R, Katz R, Berry D, Dilts D, Hanna D, Salloway S, Trojanowski JQ, Bountra C, Krams M, Luthman J, Potkin S, Gribkoff V, Temple R, Wang Y, Carrillo MC, Stephenson D, Snyder H, Liu E, Ware T, McKew J, Fields FO, Bain LJ, Bens C. Building A Roadmap For Developing Combination Therapies For Alzheimer’s Disease. Expert Review of Neurotherapeutics. 2015 Mar;15(3):327–33.

• March 1, 2015
  

  The Future Is Now: Model‐based Clinical Trial Design For Alzheimer’s Disease